scholarly article | Q13442814 |
P50 | author | Ronald Harris | Q64856485 |
Richard Kellermayer | Q95601970 | ||
Dorottya Nagy-Szakal | Q114735309 | ||
P2093 | author name string | Bela Melegh | |
Pia Munkholm | |||
Tine Jess | |||
Cathrine Jespersgaard | |||
Natalia Pedersen | |||
Antone Opekun | |||
George Ferry | |||
Jiri Bronsky | |||
PaalSkytt Andersen | |||
P2860 | cites work | Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals | Q22122053 |
Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature | Q22251115 | ||
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci | Q24618592 | ||
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality | Q28131773 | ||
The Honey Bee Epigenomes: Differential Methylation of Brain DNA in Queens and Workers | Q28475984 | ||
TEPP, a new gene specifically expressed in testis, prostate, and placenta and well conserved in chordates | Q28572655 | ||
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 | Q28943305 | ||
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences | Q29617565 | ||
Child health, developmental plasticity, and epigenetic programming | Q30466805 | ||
Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. | Q33489952 | ||
Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn's disease patients. | Q33590793 | ||
Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus | Q33618909 | ||
Season of conception in rural gambia affects DNA methylation at putative human metastable epialleles | Q33784616 | ||
Direct detection of DNA methylation during single-molecule, real-time sequencing | Q33888756 | ||
Epigenetics of inflammatory bowel disease | Q33969752 | ||
Investigating micronutrients and epigenetic mechanisms in relation to inflammatory bowel disease. | Q34100950 | ||
6-Thioguanine and S⁶-methylthioguanine are mutagenic in human cells | Q34440523 | ||
DNA methylation profiles in monozygotic and dizygotic twins. | Q34924376 | ||
Maternal methyl-donor supplementation induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes | Q35046811 | ||
Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients. | Q35673366 | ||
Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. | Q36014379 | ||
Distinct IFNG methylation in a subset of ulcerative colitis patients based on reactivity to microbial antigens | Q36104271 | ||
Inflammatory bowel disease--environmental modification and genetic determinants | Q36549025 | ||
Metastable epialleles, imprinting, and the fetal origins of adult diseases | Q36783165 | ||
Epigenetic epidemiology of the developmental origins hypothesis | Q36804691 | ||
Circulating microRNA is a biomarker of pediatric Crohn disease. | Q37254246 | ||
Epigenomic profiling indicates a role for DNA methylation in early postnatal liver development | Q37272360 | ||
Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006. | Q37733066 | ||
Inflammatory bowel disease-attributable costs and cost-effective strategies in the United States: a review | Q37807362 | ||
Epigenetic alterations in autoimmune rheumatic diseases. | Q37846094 | ||
Epidemiology of inflammatory bowel disease: Is there a shift towards onset at a younger age? | Q38437785 | ||
Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease | Q38473217 | ||
Rising incidence of inflammatory bowel disease in young children: What does the future hold? | Q39743255 | ||
Deacetylase inhibition promotes the generation and function of regulatory T cells. | Q46961808 | ||
Assessment of DNA methylation at the interferon regulatory factor 5 (IRF5) promoter region in inflammatory bowel diseases | Q47140704 | ||
Disease concordance, zygosity, and NOD2/CARD15 status: follow-up of a population-based cohort of Danish twins with inflammatory bowel disease. | Q50542832 | ||
Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease. | Q50546014 | ||
Epigenetics as a unifying principle in the aetiology of complex traits and diseases. | Q51849916 | ||
Epigenetics and twins: three variations on the theme. | Q51917525 | ||
DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. | Q53283309 | ||
“Omics” as the filtering gateway between environment and phenotype: The inflammatory bowel diseases example | Q82609061 | ||
Genetics in twins with Crohnʼs disease: Less pronounced than previously believed? | Q85043183 | ||
Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease | Q85202369 | ||
P4510 | describes a project that uses | limma | Q112236343 |
P433 | issue | 12 | |
P921 | main subject | inflammation | Q101991 |
DNA methylation | Q874745 | ||
inflammatory bowel diseases | Q917447 | ||
genome-wide association study | Q1098876 | ||
P304 | page(s) | 2334-2341 | |
P577 | publication date | 2012-03-29 | |
P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
P1476 | title | Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases | |
P478 | volume | 18 |
Q58101942 | Accelerated DNA methylation changes in middle-aged men define sexual dimorphism in human lifespans |
Q33742004 | Accounting for cellular heterogeneity is critical in epigenome-wide association studies |
Q52726132 | Allele-specific DNA methylation of disease susceptibility genes in Japanese patients with inflammatory bowel disease. |
Q55341329 | An integrated -omics analysis of the epigenetic landscape of gene expression in human blood cells. |
Q64974059 | Best practices in DNA methylation: lessons from inflammatory bowel disease, psoriasis and ankylosing spondylitis. |
Q37572837 | Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. |
Q64115892 | Cell-free DNA testing: future applications in gastroenterology and hepatology |
Q39200926 | Challenges for epigenetic research in inflammatory bowel diseases |
Q36011711 | Cohort profile: LifeLines DEEP, a prospective, general population cohort study in the northern Netherlands: study design and baseline characteristics |
Q37237816 | DNA Methylation Profiling in Inflammatory Bowel Disease Provides New Insights into Disease Pathogenesis |
Q38558521 | DNA Methylation in Whole Blood: Uses and Challenges. |
Q33740666 | DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease |
Q21183994 | DNA methylation age of human tissues and cell types |
Q42360895 | DNA methylation changes in inflammatory bowel disease |
Q26996466 | DNA methylation data analysis and its application to cancer research |
Q42142244 | DNA methylation in PRDM8 is indicative for dyskeratosis congenita |
Q36681483 | DNA methylation levels at individual age-associated CpG sites can be indicative for life expectancy |
Q34183403 | DNA methylation-associated colonic mucosal immune and defense responses in treatment-naïve pediatric ulcerative colitis. |
Q40059675 | Diet, Gut Microbiome and Epigenetics: Emerging Links with Inflammatory Bowel Diseases and Prospects for Management and Prevention |
Q36203475 | Environmental epigenetics: prospects for studying epigenetic mediation of exposure-response relationships |
Q35554170 | Epigenetic alterations in inflammatory bowel disease and cancer |
Q38694852 | Epigenetic alterations underlying autoimmune diseases |
Q27687013 | Epigenetics and the developmental origins of inflammatory bowel diseases |
Q47801332 | Epigenome-wide association study for Parkinson's disease. |
Q64101212 | Evaluating DNA methylation age on the Illumina MethylationEPIC Bead Chip |
Q97884559 | From obesity through gut microbiota to cardiovascular diseases: a dangerous journey |
Q36213255 | Genome-wide DNA methylation variability in adolescent monozygotic twins followed since birth. |
Q36669981 | Human metastable epiallele candidates link to common disorders |
Q39154509 | Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease. |
Q38217532 | Linking immunity, epigenetics, and cancer in inflammatory bowel disease |
Q52617363 | Mbd2 enables tumourigenesis within the intestine while preventing tumour-promoting inflammation. |
Q35755739 | Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases |
Q99727569 | Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis |
Q92151866 | Multi-omics integrative analysis identified SNP-methylation-mRNA: Interaction in peripheral blood mononuclear cells |
Q36980908 | Peripheral blood methylation profiling of female Crohn's disease patients |
Q47993509 | Recent Advances in the Etiopathogenesis of Inflammatory Bowel Disease: The Role of Omics. |
Q37419468 | SMAD4 haploinsufficiency associates with augmented colonic inflammation in select humans and mice |
Q38858574 | The genetic burden of inflammatory bowel diseases: implications for the clinic? |
Q64900045 | The role of diet in the prevention and treatment of Inflammatory Bowel Diseases. |
Q36530028 | Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. |
Search more.